Related Experiment Video
Updated: Jan 24, 2026

Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making
Published on: March 2, 2011
Combined dipeptidyl peptidase-4 inhibitor with low-dose testosterone exerts greater efficacy than monotherapy on
Puntarik Keawtep1, Wasana Pratchayasakul1, Apiwan Arinno1
1Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Cardiac Electrophysiology Unit, Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Center of Excellence in Cardiac Electrophysiology Research, Chiang Mai University, Chiang Mai, Thailand.
Abstract:
Both obesity and orchiectomy lead to the development of brain pathologies and cognitive decline. Testosterone replacement therapy (2 mg/kg/day TRT) and dipeptidyl peptidase-4 inhibitor (vildagliptin) improved cognition in orchiectomized rats, and obese rats. However, both had no beneficial effects in brain of orchiectomized-obese rats. TRT (>2 mg/kg/day) is possible to attenuate brain defects in those rats, but high dose of TRT causes adverse effects. Then, combined effect of low-dose TRT (1 mg/kg/day) and vildagliptin on brain and cognitive functions in orchiectomized-obese rats should be investigated. Sixty male rats were fed with either a normal diet (ND) or a high-fat diet (HFD) for 28 weeks. At week 13, both ND and HFD-fed rats had either a sham-operation or an orchiectomy. At week 25, orchiectomized rats were treated with either: a vehicle, 2 mg/kg/day TRT, vildagliptin (3 mg/kg/day) or a combined vildagliptin with 1 mg/kg/day TRT for 4 weeks. Then, metabolic parameters, brain and cognitive functions were determined. Hippocampal oxidative stress, apoptosis, dendritic spine loss, microglial hyperactivity, and cognitive decline were found in orchiectomized ND-fed rats and sham-operated HFD-fed rats. Interestingly, orchiectomy aggravated these brain pathologies and cognitive decline in HFD-fed rats. In orchiectomized ND-fed rats, all treatments restored brain and cognitive functions. In orchiectomized HFD-fed rats, monotherapies ameliorated these brain pathologies, while the combined therapies had the greatest beneficial effect on the brains. These findings suggest the combined therapies may be the best therapeutic approach for restoring brain functions in the orchiectomized-obese condition.
Insights
Combined low-dose testosterone replacement therapy (TRT) and vildagliptin show promise for improving brain health and cognition in orchiectomized-obese rats. This combination therapy offers a potential therapeutic strategy for this complex condition.
Area of Science:
- Neuroscience
- Endocrinology
- Metabolic Syndrome
Background:
- Obesity and orchiectomy independently contribute to brain pathologies and cognitive decline.
- Existing treatments like testosterone replacement therapy (TRT) and vildagliptin show benefits in individual conditions but not in the combined orchiectomized-obese state.
- High-dose TRT can mitigate brain defects but carries adverse effects, necessitating investigation into alternative therapeutic combinations.
Purpose of the Study:
- To investigate the combined effects of low-dose TRT (1 mg/kg/day) and vildagliptin on brain function and cognitive performance in orchiectomized-obese rats.
- To determine if this combination therapy can overcome the limitations of monotherapies in addressing neuroinflammation, oxidative stress, and cognitive deficits.
Main Methods:
- Sixty male rats were fed either a normal diet (ND) or a high-fat diet (HFD) for 28 weeks.
- Orchiectomy or sham-operation was performed at week 13.
- At week 25, orchiectomized rats received vehicle, 2 mg/kg/day TRT, 3 mg/kg/day vildagliptin, or a combination of 1 mg/kg/day TRT and vildagliptin for 4 weeks.
Main Results:
- Orchiectomy aggravated hippocampal oxidative stress, apoptosis, dendritic spine loss, microglial hyperactivity, and cognitive decline in HFD-fed rats.
- While monotherapies partially ameliorated these brain pathologies in orchiectomized HFD-fed rats, the combined therapy demonstrated the most significant beneficial effects.
- All tested treatments restored brain and cognitive functions in orchiectomized ND-fed rats.
Conclusions:
- Combined low-dose TRT and vildagliptin therapy is a promising approach for restoring brain function and cognitive performance in orchiectomized-obese rats.
- This combination therapy may offer a superior therapeutic strategy compared to monotherapies for addressing the complex neurobiological consequences of combined obesity and orchiectomy.
More Related Videos
09:51Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
Published on: June 30, 2023
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
Related Concept Videos
Dipeptidyl Peptidase 4 Inhibitors
Drug Dosing: Obese Patients
Testosterone: Functions and Regulation
Dose-Response Relationship: Potency and Efficacy
Obesity
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...